Assertion: chronic lymphocytic leukemia | /r/CapableOf | carry deletion
Facets:
value: in chromosome
type: LOCATION
Source sentences:
text: The U.S. Food and Drug Administration (FDA) expanded the approved use of ibrutinib (Imbruvica) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL.